» Articles » PMID: 38029215

Breastmilk Microbiome Changes Associated with Lactational Mastitis and Treatment with Dandelion Extract

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2023 Nov 29
PMID 38029215
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Dandelion (Pugongying) is one of the most frequently used Chinese herbs for treating lactational mastitis (LM). Pugongying granules, a patented medication primarily comprised of dandelion extract, have been approved by CFDA for LM treatment in China. The aims of this study were to investigate the etiology of LM and the mechanism by which Pugongying granules decrease LM symptoms, with a particular focus on the microbial communities found in breastmilk.

Methods: Participants were recruited from a previously performed randomized controlled trial (Identifier: NCT03756324, ClinicalTrials.gov). Between 2019 and 2020, women diagnosed with unilateral LM at the Beijing University of Chinese Medicine Third Affiliated Hospital were enrolled. In total, 42 paired breastmilk samples from the healthy and affected breasts of the participants were collected. Additionally, 37 paired pre- and post-treatment breastmilk samples from the affected breast were collected from women who received a 3-day course of either Pugongying granules (20 women) or cefdinir (17 women). Clinical outcomes [e.g., body temperature, visual analogue scale (VAS) score for breast pain, the percentage of neutrophils (NE%)] were analyzed pre- and post-treatment, and the breastmilk samples were subjected to 16S rRNA gene sequencing to analyze the alpha and beta diversities and identify significant bacteria. Finally, the relationship between microorganisms and clinical outcomes was analyzed.

Results: There was no significant difference in fever and pain between the Pugongying group and cefdinir group. The most prevalent bacterial genera in breastmilk were and . Compared to healthy breastmilk, microbial diversity was reduced in affected breastmilk, and there was a higher relative abundance of . After Pugongying treatment, there was an increase in microbial diversity with significantly higher abundance of . A negative correlation was found between , VAS score, and NE%. Treatment with cefdinir did not affect microbial diversity. Taken together, our results show a correlation between LM and reduced microbial diversity, as well as an increased abundance of in affected breastmilk.

Conclusion: Pugongying granules enhanced microbial diversity in breastmilk samples. Given the substantial variation in individual microbiomes, identifying specific species of and associated with LM may provide additional insight into LM pathogenesis and treatment.

Citing Articles

Integrating the milk microbiome signatures in mastitis: milk-omics and functional implications.

Reuben R, Torres C World J Microbiol Biotechnol. 2025; 41(2):41.

PMID: 39826029 PMC: 11742929. DOI: 10.1007/s11274-024-04242-1.

References
1.
Consales A, Cerasani J, Sorrentino G, Morniroli D, Colombo L, Mosca F . The hidden universe of human milk microbiome: origin, composition, determinants, role, and future perspectives. Eur J Pediatr. 2022; 181(5):1811-1820. PMC: 9056486. DOI: 10.1007/s00431-022-04383-1. View

2.
Patel S, Vaidya Y, Patel R, Pandit R, Joshi C, Kunjadiya A . Culture independent assessment of human milk microbial community in lactational mastitis. Sci Rep. 2017; 7(1):7804. PMC: 5552812. DOI: 10.1038/s41598-017-08451-7. View

3.
Cooney F, Petty-Saphon N . The Burden of Severe Lactational Mastitis in Ireland from 2006 to 2015. Ir Med J. 2019; 112(1):855. View

4.
McGuire M, McGuire M . Got bacteria? The astounding, yet not-so-surprising, microbiome of human milk. Curr Opin Biotechnol. 2016; 44:63-68. DOI: 10.1016/j.copbio.2016.11.013. View

5.
Heikkila M, Saris P . Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. J Appl Microbiol. 2003; 95(3):471-8. DOI: 10.1046/j.1365-2672.2003.02002.x. View